1.Research development of scaffolds for engineering cartilage
Junhang HAO ; Jian HAO ; Zhe PIAO ; Jihai LI
International Journal of Biomedical Engineering 2011;34(6):380-382,后插2
Transplantation of engineering cartilage is a better choice for the treatment of articular cartilage lesions.Constructing engineering cartilage needs seeded cells and scaffold materials.The property of scaffold materials has a great influence on the biomechanical features of engineering cartilage.A variety of materials can be used for constructing engineering cartilaginous framework.Exploring the research development of scaffold materials and comparing the effects of their clinical applications is of great significance for further improvement of biomechanical characteristics of the engineering cartilage.
2.Expression of Class I and Class II a/b Histone Deacetylase is Dysregulated in Hypertensive Animal Models.
Hae Jin KEE ; Gwi Ran KIM ; Ming Quan LIN ; Sin Young CHOI ; Yuhee RYU ; Li JIN ; Zhe Hao PIAO ; Myung Ho JEONG
Korean Circulation Journal 2017;47(3):392-400
BACKGROUND AND OBJECTIVES: Dysregulation of histone deacetylase expression and enzymatic activity is associated with a number of diseases. It has been reported that protein levels of histone deacetylase (HDAC)1 and HDAC5 increase during human pulmonary hypertension, and that the enzymatic activity of HDAC6 is induced in a chronic hypertensive animal model. This study investigated the protein expression profiles of class I and II a/b HDACs in three systemic hypertension models. SUBJECTS AND METHODS: We used three different hypertensive animal models: (i) Wistar-Kyoto rats (n=8) and spontaneously hypertensive rats (SHR; n=8), (ii) mice infused with saline or angiotensin II to induce hypertension, via osmotic mini-pump for 2 weeks, and (iii) mice that were allowed to drink L-N(G)-nitro-L-arginine methyl ester (L-NAME) to induce hypertension. RESULTS: SHR showed high systolic, diastolic, and mean blood pressures. Similar increases in systolic blood pressure were observed in angiotensin II or L-NAME-induced hypertensive mice. In SHR, class IIa HDAC (HDAC4, 5, and 7) and class IIb HDAC (HDAC6 and 10) protein expression were significantly increased. In addition, a HDAC3 protein expression was induced in SHR. However, in L-NAME mice, class IIa HDAC protein levels (HDAC4, 5, 7, and 9) were significantly reduced. HDAC8 protein levels were significantly reduced both in angiotensin II mice and in SHR. CONCLUSION: These results indicate that dysregulation of class I and class II HDAC protein is closely associated with chronic hypertension.
Angiotensin II
;
Animals*
;
Blood Pressure
;
Histone Deacetylases*
;
Histones*
;
Humans
;
Hypertension
;
Hypertension, Pulmonary
;
Mice
;
Models, Animal*
;
NG-Nitroarginine Methyl Ester
;
Rats
;
Rats, Inbred SHR
3.Coronary Artery Fistula with Giant Aneurysm and Coronary Stenosis Treated by Transcatheter Embolization and Stent.
Zhe Hao PIAO ; Myung Ho JEONG ; Hae Chang JEONG ; Keun Ho PARK ; Doo Sun SIM ; Young Joon HONG ; Ju Han KIM ; Youngkeun AHN
Korean Circulation Journal 2015;45(3):245-247
Coronary artery fistula (CAF) with giant aneurysm and accompanied by coronary artery stenosis is a very rare disease. Herein, we report a case of a 76-year-old woman having a complex coronary-to-pulmonary artery fistula associated with a giant aneurysm and accompanied by coronary artery stenosis. The patient was successfully treated using transcatheter coil embolization and coronary stent implantation. Eight years later, we performed a follow-up coronary angiogram, which revealed the CAF and the aneurysm were completely occluded and previous stent patency.
Aged
;
Aneurysm*
;
Arteries
;
Arteriovenous Fistula
;
Coronary Aneurysm
;
Coronary Stenosis*
;
Coronary Vessels*
;
Embolization, Therapeutic
;
Female
;
Fistula*
;
Follow-Up Studies
;
Humans
;
Rare Diseases
;
Stents*
4.Successful Percutaneous Coronary Intervention in a Young Male Systemic Lupus Erythematosus Patient with Acute Myocardial Infarction.
Zhe Hao PIAO ; Myung Ho JEONG ; Hae Chang JEONG ; Shi Hyun RHEW ; Ki Hong LEE ; Keun Ho PARK ; Doo Sun SIM ; Young Joon HONG ; Ju Han KIM ; Youngkeun AHN ; Jeong Gwan CHO ; Jong Chun PARK
Journal of Lipid and Atherosclerosis 2013;2(2):91-95
Acute myocardial infarction is a rare but potentially lethal complication of systemic lupus erythematosus. There are several proposed mechanisms for acute myocardial infarction in lupus patients: atherosclerosis and endothelial injury leading to plaque rupture, coronary vasculitis and inflammation of the vessel wall causing aneurismal dilatation or spasm, and acute thrombosis and embolism. We report a-37-year-old man with systemic lupus erythematosus who developed myocardial infarction twice. Potential mechanisms for acute myocardial infarction for this patient are discussed in this report.
Atherosclerosis
;
Dilatation
;
Embolism and Thrombosis
;
Humans
;
Inflammation
;
Lupus Erythematosus, Systemic*
;
Male*
;
Myocardial Infarction*
;
Percutaneous Coronary Intervention*
;
Rupture
;
Spasm
;
Vasculitis